Cargando…

Impairment of Base Excision Repair in Dermal Fibroblasts Isolated From Nevoid Basal Cell Carcinoma Patients

The nevoid basal cell carcinoma syndrome (NBCCS), also called Gorlin syndrome is an autosomal dominant disorder whose incidence is estimated at about 1 per 55,600–256,000 individuals. It is characterized by several developmental abnormalities and an increased predisposition to the development of bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Charazac, Aurélie, Fayyad, Nour, Beal, David, Bourgoin-Voillard, Sandrine, Seve, Michel, Sauvaigo, Sylvie, Lamartine, Jérôme, Soularue, Pascal, Moratille, Sandra, Martin, Michèle T., Ravanat, Jean-Luc, Douki, Thierry, Rachidi, Walid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427476/
https://www.ncbi.nlm.nih.gov/pubmed/32850458
http://dx.doi.org/10.3389/fonc.2020.01551
_version_ 1783570885230198784
author Charazac, Aurélie
Fayyad, Nour
Beal, David
Bourgoin-Voillard, Sandrine
Seve, Michel
Sauvaigo, Sylvie
Lamartine, Jérôme
Soularue, Pascal
Moratille, Sandra
Martin, Michèle T.
Ravanat, Jean-Luc
Douki, Thierry
Rachidi, Walid
author_facet Charazac, Aurélie
Fayyad, Nour
Beal, David
Bourgoin-Voillard, Sandrine
Seve, Michel
Sauvaigo, Sylvie
Lamartine, Jérôme
Soularue, Pascal
Moratille, Sandra
Martin, Michèle T.
Ravanat, Jean-Luc
Douki, Thierry
Rachidi, Walid
author_sort Charazac, Aurélie
collection PubMed
description The nevoid basal cell carcinoma syndrome (NBCCS), also called Gorlin syndrome is an autosomal dominant disorder whose incidence is estimated at about 1 per 55,600–256,000 individuals. It is characterized by several developmental abnormalities and an increased predisposition to the development of basal cell carcinomas (BCCs). Cutaneous fibroblasts from Gorlin patients have been shown to exhibit an increased sensitivity to ionizing radiations. Mutations in the tumor suppressor gene PTCH1, which is part of the Sonic Hedgehog (SHH) signaling pathway, are responsible for these clinical manifestations. As several genetic mutations in the DNA repair genes are responsible of photo or radiosensitivity and high predisposition to cancers, we hypothesized that these effects in Gorlin syndrome might be due to a defect in the DNA damage response (DDR) and/or the DNA repair capacities. Therefore, the objective of this work was to investigate the sensitivity of skin fibroblasts from NBCCS patients to different DNA damaging agents and to determine the ability of these agents to modulate the DNA repair capacities. Gorlin fibroblasts showed high radiosensitivity and also less resistance to oxidative stress-inducing agents when compared to control fibroblasts obtained from healthy individuals. Gorlin fibroblasts harboring PTCH1 mutations were more sensitive to the exposure to ionizing radiation and to UVA. However, no difference in cell viability was shown after exposure to UVB or bleomycin. As BER is responsible for the repair of oxidative DNA damage, we decided to assess the BER pathway efficacy in Gorlin fibroblasts. Interestingly, a concomitant decrease of both BER gene expression and BER protein activity was observed in Gorlin fibroblasts when compared to control. Our results suggest that low levels of DNA repair within Gorlin cells may lead to an accumulation of oxidative DNA damage that could participate and partly explain the radiosensitivity and the BCC-prone phenotype in Gorlin syndrome.
format Online
Article
Text
id pubmed-7427476
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74274762020-08-25 Impairment of Base Excision Repair in Dermal Fibroblasts Isolated From Nevoid Basal Cell Carcinoma Patients Charazac, Aurélie Fayyad, Nour Beal, David Bourgoin-Voillard, Sandrine Seve, Michel Sauvaigo, Sylvie Lamartine, Jérôme Soularue, Pascal Moratille, Sandra Martin, Michèle T. Ravanat, Jean-Luc Douki, Thierry Rachidi, Walid Front Oncol Oncology The nevoid basal cell carcinoma syndrome (NBCCS), also called Gorlin syndrome is an autosomal dominant disorder whose incidence is estimated at about 1 per 55,600–256,000 individuals. It is characterized by several developmental abnormalities and an increased predisposition to the development of basal cell carcinomas (BCCs). Cutaneous fibroblasts from Gorlin patients have been shown to exhibit an increased sensitivity to ionizing radiations. Mutations in the tumor suppressor gene PTCH1, which is part of the Sonic Hedgehog (SHH) signaling pathway, are responsible for these clinical manifestations. As several genetic mutations in the DNA repair genes are responsible of photo or radiosensitivity and high predisposition to cancers, we hypothesized that these effects in Gorlin syndrome might be due to a defect in the DNA damage response (DDR) and/or the DNA repair capacities. Therefore, the objective of this work was to investigate the sensitivity of skin fibroblasts from NBCCS patients to different DNA damaging agents and to determine the ability of these agents to modulate the DNA repair capacities. Gorlin fibroblasts showed high radiosensitivity and also less resistance to oxidative stress-inducing agents when compared to control fibroblasts obtained from healthy individuals. Gorlin fibroblasts harboring PTCH1 mutations were more sensitive to the exposure to ionizing radiation and to UVA. However, no difference in cell viability was shown after exposure to UVB or bleomycin. As BER is responsible for the repair of oxidative DNA damage, we decided to assess the BER pathway efficacy in Gorlin fibroblasts. Interestingly, a concomitant decrease of both BER gene expression and BER protein activity was observed in Gorlin fibroblasts when compared to control. Our results suggest that low levels of DNA repair within Gorlin cells may lead to an accumulation of oxidative DNA damage that could participate and partly explain the radiosensitivity and the BCC-prone phenotype in Gorlin syndrome. Frontiers Media S.A. 2020-08-07 /pmc/articles/PMC7427476/ /pubmed/32850458 http://dx.doi.org/10.3389/fonc.2020.01551 Text en Copyright © 2020 Charazac, Fayyad, Beal, Bourgoin-Voillard, Seve, Sauvaigo, Lamartine, Soularue, Moratille, Martin, Ravanat, Douki and Rachidi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Charazac, Aurélie
Fayyad, Nour
Beal, David
Bourgoin-Voillard, Sandrine
Seve, Michel
Sauvaigo, Sylvie
Lamartine, Jérôme
Soularue, Pascal
Moratille, Sandra
Martin, Michèle T.
Ravanat, Jean-Luc
Douki, Thierry
Rachidi, Walid
Impairment of Base Excision Repair in Dermal Fibroblasts Isolated From Nevoid Basal Cell Carcinoma Patients
title Impairment of Base Excision Repair in Dermal Fibroblasts Isolated From Nevoid Basal Cell Carcinoma Patients
title_full Impairment of Base Excision Repair in Dermal Fibroblasts Isolated From Nevoid Basal Cell Carcinoma Patients
title_fullStr Impairment of Base Excision Repair in Dermal Fibroblasts Isolated From Nevoid Basal Cell Carcinoma Patients
title_full_unstemmed Impairment of Base Excision Repair in Dermal Fibroblasts Isolated From Nevoid Basal Cell Carcinoma Patients
title_short Impairment of Base Excision Repair in Dermal Fibroblasts Isolated From Nevoid Basal Cell Carcinoma Patients
title_sort impairment of base excision repair in dermal fibroblasts isolated from nevoid basal cell carcinoma patients
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427476/
https://www.ncbi.nlm.nih.gov/pubmed/32850458
http://dx.doi.org/10.3389/fonc.2020.01551
work_keys_str_mv AT charazacaurelie impairmentofbaseexcisionrepairindermalfibroblastsisolatedfromnevoidbasalcellcarcinomapatients
AT fayyadnour impairmentofbaseexcisionrepairindermalfibroblastsisolatedfromnevoidbasalcellcarcinomapatients
AT bealdavid impairmentofbaseexcisionrepairindermalfibroblastsisolatedfromnevoidbasalcellcarcinomapatients
AT bourgoinvoillardsandrine impairmentofbaseexcisionrepairindermalfibroblastsisolatedfromnevoidbasalcellcarcinomapatients
AT sevemichel impairmentofbaseexcisionrepairindermalfibroblastsisolatedfromnevoidbasalcellcarcinomapatients
AT sauvaigosylvie impairmentofbaseexcisionrepairindermalfibroblastsisolatedfromnevoidbasalcellcarcinomapatients
AT lamartinejerome impairmentofbaseexcisionrepairindermalfibroblastsisolatedfromnevoidbasalcellcarcinomapatients
AT soularuepascal impairmentofbaseexcisionrepairindermalfibroblastsisolatedfromnevoidbasalcellcarcinomapatients
AT moratillesandra impairmentofbaseexcisionrepairindermalfibroblastsisolatedfromnevoidbasalcellcarcinomapatients
AT martinmichelet impairmentofbaseexcisionrepairindermalfibroblastsisolatedfromnevoidbasalcellcarcinomapatients
AT ravanatjeanluc impairmentofbaseexcisionrepairindermalfibroblastsisolatedfromnevoidbasalcellcarcinomapatients
AT doukithierry impairmentofbaseexcisionrepairindermalfibroblastsisolatedfromnevoidbasalcellcarcinomapatients
AT rachidiwalid impairmentofbaseexcisionrepairindermalfibroblastsisolatedfromnevoidbasalcellcarcinomapatients